Home World News AstraZeneca gets clearance by US regulators to resume coronavirus vaccine trial

AstraZeneca gets clearance by US regulators to resume coronavirus vaccine trial

0


Image Source : AP

FILE

Biopharmaceutical giant AstraZeneca, developing a coronavirus vaccine with the University of Oxford, has got clearance by U.S. regulators to restart a halted trial after concerns about a volunteer falling ill. According to AstraZeneca and Oxford, the FDA reviewed data from global studies and decided it was safe to begin testing again. 

Among the front-runners in the global quest for a vaccine, Astra’s U.S. trial will test the shot on 30,000 volunteers, taking the total number of participants in advanced trials for the jab to 50,000. 

“We should be reassured by the care taken by independent regulators to protect the public and ensure the vaccine is safe before it is approved for use,” Pascal Soriot, the drugmaker’s chief executive officer, said in a statement. This “allows us to continue our efforts to develop this vaccine to help defeat this terrible pandemic.

Latest News on Coronavirus

Latest World News

Fight against Coronavirus: Full coverage





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here